Description
Sitawalk M 100/500 PR is a combination of Sitagliptin Phosphate Monohydrate (100 mg) and Metformin Hydrochloride Prolonged Release (500 mg). This medicine is prescribed to manage Type 2 Diabetes Mellitus, helping to control blood sugar levels effectively. The dual action of Sitagliptin and Metformin ensures improved glycemic control with a prolonged release mechanism for better patient compliance.
Composition (per tablet):
-
Sitagliptin Phosphate Monohydrate eq. to Sitagliptin – 100 mg
-
Metformin Hydrochloride (Prolonged Release) – 500 mg
-
Excipients – q.s.
Pack Size: 10 x 10 Tablets (Box of 100 Tablets)
MRP: ₹1400/Box
GST: 12%
Key Benefits:
-
Helps in managing Type 2 Diabetes Mellitus
-
Improves insulin sensitivity and glucose tolerance
-
Prolonged release for steady blood sugar control
-
Reduces risk of diabetes-related complications
⚠️ Note: Use only under the guidance of a registered medical practitioner.
Franchise Welcome
Biophar Lifesciences Pvt. Ltd. invites dedicated pharma professionals and entrepreneurs to join hands with us through our Pharma Franchise / PCD Pharma opportunities. With a wide range of quality-assured medicines, strong marketing support, monopoly rights, and timely delivery, we provide an excellent platform to start and grow your pharmaceutical business. Partner with us today and become a part of India’s fastest-growing healthcare network.
